In Review: The Joint Interim Health Care Committee met last Monday, and the focus was on the Prescription Drug Transparency Reporting Study (340B). There were presentations to the Committee from the Insurance Commissioner Jon Godfread (R), Department of Health and Human Services,
In Review: Legislative Management met last Wednesday and considered the various study resolutions and bills for purposes of establishing priorities for the 2025-2026 interim. While the issues of “Prescription Drug Pricing” and “Non-Opioid Treatment Options to Reduce Pain” were not approved, the
In Review: Senate Bill 2370, which formerly was an insulin copay bill, was amended (or, as some refer to it, hog-housed) to be a 340B reporting bill but turned into a study bill and sent to the Governor on May 1. HB 1216 (copay
In Review: PCMA submitted its veto letter to the Governor’s Office on HB 1584 (remove ERISA exemption). It is our understanding that none of the coalition members submitted veto letters. The Governor signed SB 2280 (prior authorization) into law on April 21. SB 2370, which formerly was
In Review: The full Senate Appropriations Committee held Committee Work on HB 1584 (remove ERISA exemption) and gave it a “do pass as amended” recommendation. The amendment that was passed scaled back the proposed staffing and restructured how the Department of Insurance would be
In Review: The Senate Appropriations – Government Operations Division held a hearing and Committee Work on HB 1584 (Remove ERISA Exemption). While the Department of Insurance (DOI) has a large fiscal note for the bill, the members expressed that they were getting calls
In Review: The Senate Industry and Business Committee held a hearing on HB 1584 (remove ERISA exemption) last Monday, and testifying in opposition to the bill were PCMA, the Greater North Dakota Chamber of Commerce, North Dakota Banker’s Association, Blue Cross Blue Shield
In Review: The House Industry, Business, and Labor Committee had Committee Work on SB 2280 (prior authorization), and we have heard more amendments are coming. The Senate passed and then reconsidered HB 1216 (copay accumulator) even though it received a “do not pass as amended”
In Review: A hearing was held in the House Industry, Business, and Labor Committee on March 24 on SB 2280 (prior authorization). HB 1216 (copay accumulator) received a “do not pass as amended” recommendation from the Senate Human Services Committee and will be voted on by
In Review: A hearing was held on HB 1216 (copay accumulator) in the Senate Human Services Committee. The health plans suggested that the PBMs not get involved in this matter, so PCMA did not submit testimony. Up Next: We have heard the hearing
